Free morning briefing · 07:30 weekdays
The RNS that moves prices, in your inbox before the open.
AI-ranked movers and high-impact RNS across the FTSE 100, 250, SmallCap and AIM — one short email, every market day.
Get the briefing
GNS

Genus plc

GNSLSEUnited KingdomHealthcareBiotechnologyFTSE 250

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef…more

P/E5.11xP/B1.87xDividend yield1.6%
£1.44B
Market Cap
EV: £1.48B
MOM2
QUAL8
VAL6
RSK3
GNS
£1.44B
Market Cap · EV £1.48B

Genus plc

MOM2
QUAL8
VAL6
RSK3

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef…more

Latest RNS from Genus plc

All GNS news → · RNS daily feed

Analyst consensus: Buy

As of 6 Oct 2026, 13 analysts rate Genus plc a Buy, with 85% buy ratings and a mean price target of 3,040p (range 2,350p–3,700p), +42% vs the current price.

Strong buy: 1Buy: 10Hold: 2Sell: 0Strong sell: 0

Full analyst history →

More Healthcare companies